BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33431842)

  • 1. Stabilizing the closed SARS-CoV-2 spike trimer.
    Juraszek J; Rutten L; Blokland S; Bouchier P; Voorzaat R; Ritschel T; Bakkers MJG; Renault LLR; Langedijk JPM
    Nat Commun; 2021 Jan; 12(1):244. PubMed ID: 33431842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural impact on SARS-CoV-2 spike protein by D614G substitution.
    Zhang J; Cai Y; Xiao T; Lu J; Peng H; Sterling SM; Walsh RM; Rits-Volloch S; Zhu H; Woosley AN; Yang W; Sliz P; Chen B
    Science; 2021 Apr; 372(6541):525-530. PubMed ID: 33727252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2.
    Wrobel AG; Benton DJ; Xu P; Calder LJ; Borg A; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Commun; 2021 Feb; 12(1):837. PubMed ID: 33547281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.
    Xia X
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33466921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation.
    McCallum M; Walls AC; Bowen JE; Corti D; Veesler D
    Nat Struct Mol Biol; 2020 Oct; 27(10):942-949. PubMed ID: 32753755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain.
    Antonopoulos A; Broome S; Sharov V; Ziegenfuss C; Easton RL; Panico M; Dell A; Morris HR; Haslam SM
    Glycobiology; 2021 Apr; 31(3):181-187. PubMed ID: 32886791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
    Rui L; Haonan L; Wanyi C
    Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.
    Prahlad J; Struble LR; Lutz WE; Wallin SA; Khurana S; Schnaubelt A; Broadhurst MJ; Bayles KW; Borgstahl GEO
    Protein Sci; 2021 Sep; 30(9):1983-1990. PubMed ID: 34191362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect.
    Oliva R; Shaikh AR; Petta A; Vangone A; Cavallo L
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.
    Gobeil SM; Janowska K; McDowell S; Mansouri K; Parks R; Manne K; Stalls V; Kopp MF; Henderson R; Edwards RJ; Haynes BF; Acharya P
    Cell Rep; 2021 Jan; 34(2):108630. PubMed ID: 33417835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.
    Xu C; Wang Y; Liu C; Zhang C; Han W; Hong X; Wang Y; Hong Q; Wang S; Zhao Q; Wang Y; Yang Y; Chen K; Zheng W; Kong L; Wang F; Zuo Q; Huang Z; Cong Y
    Sci Adv; 2021 Jan; 7(1):. PubMed ID: 33277323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SARS-CoV-2 spike protein: balancing stability and infectivity.
    Berger I; Schaffitzel C
    Cell Res; 2020 Dec; 30(12):1059-1060. PubMed ID: 33139926
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron's molecular structure could help explain its global takeover.
    Kwon D
    Nature; 2022 Feb; 602(7897):373-374. PubMed ID: 35115694
    [No Abstract]   [Full Text] [Related]  

  • 17. A thermostable, closed SARS-CoV-2 spike protein trimer.
    Xiong X; Qu K; Ciazynska KA; Hosmillo M; Carter AP; Ebrahimi S; Ke Z; Scheres SHW; Bergamaschi L; Grice GL; Zhang Y; ; Nathan JA; Baker S; James LC; Baxendale HE; Goodfellow I; Doffinger R; Briggs JAG
    Nat Struct Mol Biol; 2020 Oct; 27(10):934-941. PubMed ID: 32737467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation.
    Yang TJ; Yu PY; Chang YC; Hsu SD
    J Biol Chem; 2021 Oct; 297(4):101238. PubMed ID: 34563540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 beta variant substitutions alter spike glycoprotein receptor binding domain structure and stability.
    Moss DL; Rappaport J
    J Biol Chem; 2021 Dec; 297(6):101371. PubMed ID: 34756892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediates in SARS-CoV-2 spike-mediated cell entry.
    Marcink TC; Kicmal T; Armbruster E; Zhang Z; Zipursky G; Golub KL; Idris M; Khao J; Drew-Bear J; McGill G; Gallagher T; Porotto M; des Georges A; Moscona A
    Sci Adv; 2022 Aug; 8(33):eabo3153. PubMed ID: 35984891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.